Sujal M. Patel's Insider Trades & SAST Disclosures
Sujal M. Patel's most recent trade in Nautilus Biotechnology Inc was a trade of 53,300 Common Stock done at an average price of $1.0 . Disclosure was reported to the exchange on March 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sujal M. Patel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.99 per share. | 19 Mar 2025 | 53,300 | 10,117,788 | - | 1.0 | 53,028 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 19 Mar 2025 | 23,933 | 10,141,721 | - | 1.0 | 23,890 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.84 per share. | 08 Mar 2024 | 12,044 | 10,064,488 | - | 2.8 | 34,216 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 08 Mar 2024 | 2,430 | 10,052,444 | - | 3.0 | 7,262 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.89 per share. | 05 Mar 2024 | 18,854 | 10,050,014 | - | 2.9 | 54,424 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 05 Mar 2024 | 9,267 | 10,031,160 | - | 2.7 | 25,034 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.65 per share. | 05 Mar 2024 | 7,405 | 10,021,893 | - | 2.6 | 19,597 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.92 per share. | 05 Aug 2022 | 41,654 | 10,006,142 | - | 2.9 | 121,646 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.93 per share. | 05 Aug 2022 | 8,346 | 10,014,488 | - | 2.9 | 24,444 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.96 per share. | 09 May 2022 | 50,000 | 9,964,488 | - | 4.0 | 198,000 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 03 Mar 2022 | 50,000 | 9,914,388 | - | 3.6 | 179,890 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 03 Mar 2022 | 100 | 9,914,488 | - | 10 | 1,000 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2022 | 100 | 788,733 | - | - | Stock Option (Right to Buy) | |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.72 per share. | 30 Nov 2021 | 161,978 | 9,776,366 | - | 4.7 | 764,779 | Common Stock |
| Nautilus Biotechnology Inc | Sujal M. Patel | Director, CEO, President, and Secretary, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.73 per share. | 30 Nov 2021 | 88,022 | 9,864,388 | - | 4.7 | 416,397 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges